Transoral dosage forms comprising sufentanil and naloxone

Details for Australian Patent Application No. 2008216867 (hide)

Owner Durect Corporation

Inventors Shah, Jaymin; Yum, Su Il; Song, Xiaoping; Kwon, Sung Yun

Agent FB Rice

Pub. Number AU-A-2008216867

PCT Pub. Number WO2008/100434

Priority 60/904,585 02.03.07 US; 60/900,661 09.02.07 US

Filing date 8 February 2008

Wipo publication date 21 August 2008

International Classifications

A61K 31/4535 (2006.01)

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

Event Publications

27 August 2009 PCT application entered the National Phase

  PCT publication WO2008/100434 Priority application(s): WO2008/100434

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008216869-Multicomponent viscoelastic surfactant fluid and method of using as a fracturing fluid

2008216866-Pelvic balloon tamponade